维普中文期刊产品整合服务
68篇 您的检索式:作者名="Emanuela C"
    题名 作者 年代 出处 被引量
1Prognostic and predictive biomarkers in metastatic colorectal cancer anti-EGFR therapy显示文摘AIM: To reviewing genetic and epigenetic make-up of metastatic colorectal cancers(m CRCs) addicted to epidermal growth factor receptor(EGFR) signalling.METHODS: The present study summarizes the potential value of prognostic and predictive biomarkers in selecting m CRC patients treated with anti-EGFR therapy. A meta-analysis was performed using a systematic search of Pub Med, Medline and Web of Science to identify eligible papers until March 21 st, 2016 using these following terms: ‘‘colorectal cancer'', 'predictive biomarkers' ', 'anti-EGFR therapy', 'KRAS', 'NRAS'', 'PIK3CA', 'TP53', 'PTEN', ‘‘EGFR', 'MET', 'HER2', 'epiregulin', 'amphiregulin', 'prognostic biomarkers', 'BRAF', 'miR NA' and 'antibody-dependent cell-mediated cytotoxicity(ADCC) activity'. Two investigators independently evaluated and extracted data from each identified studies based on selected criteria of inclusion and exclusion. RESULTS: The introduction of agents targeting EGFR such as cetuximab and panitumumab increased overall survival of mC RCs. Nevertheless, it has firstly became evident that response rates to cetuximab regimens in unselected patient populations were typically lower than 30%. Clinical data confirmed the predictive value of RAS mutations for resistance to cetuximab and panitumumab leading to the license of these monoclonal antibodies exclusively for the management of patients with RAS-wild type colorectal cancers. So far the identification of predictive biomarkers have generated interesting, though preliminary and, at times, conflicting data on the importance of tumour mR NA levels of EGFR ligands, of activating mutations in other genes such as NRAS and PIK3 CA. The prognostic value of selected micro RNAs level and ADCC activity is under investigation, while the prognostic impact of BRAF status remains controversial.CONCLUSION: This review focuses on the personalized treatment of m CRC and discusses the potential of new prognostic and predictive biomarkers in selecting patients treated with anti-EGFR therapy.Cristiana Lo Nigro Vincenzo Ricci Daniela Vivenza Cristina Granetto Teresa Fabozzi Emanuela Miraglio Marco C Merlano 2016World Journal of Gastroenterology2016,22,30:5
2Relief of pruritus and decrease in plasma histamine concentrations during erythropoietin therapy in patients with uremia显示文摘Sergio D Emanuela C Danilo V et a1 1992N Eng J Med1992,326,1:1
3Protective effects of N-acetylcysteine on lung injury and red blood cell modification induced by carrageenan in the rat显示文摘Salvatore C Emanuela M laura D 2001FASEB J2001,15,:1
4Relif ofpruritus and decrese in plasna hiatanine concentvations during erythropoietin therapy in patients with arenia显示文摘Serigo D Emanuela C Danilo V 1992N Engl J Med1992,326,:1
5Relief of pruitus and de- crease in piasma histamine concentrations during erythropoietin therapy in patients with uremia显示文摘Sergip D Emanuela C DaniloV 1992N Engl J Med1992,326,1:1
6Proyecyive effects of N-acetylcysteine on lung injury and red blood cell modification insuced by carrageenan in the rat显示文摘Salvatore C Emanuela M Laura D 2001FASEB J2001,15,:1
7Protective effects of N- acetycysteine on lung injury and red blood cell modification induced by carrageenan in the rat 显示文摘Salvatore C Emanuela M Laura D 2001Paseb J2001,15,7:1
8Quantitative PCR of bone marrow BCL2/IgH cells at diagnosis predicts treatment response and long-term outcome in follicular non-Hodgkin lymphoma显示文摘Alessandro R Emanuela C Elena O 2005Blood2005,105,9:1
9Relief of pruritus anti decrease in plasma histamine concentrations during erythropoietin therapy in patients with uremia显示文摘Sergio D Emanuela C Danilo V 1992N Engl J Med1992,326,:1
10Relief of pruritus and decrease in plasma histamine concentrations during erythropoietin therapy in patients with uremia显示文摘Sergio D Emanuela C Danilo V 1992N Engl J Med1992,326,:1
11Relief of pruritus and decrease inplasma histamine concentrations during erythropoietin therapy in patientswith uremia显示文摘Sergio D Emanuela C Danilo V 1992JMed1992,326,:1
12Relief of Pruritu and Decrease in Plasma Histamine Comcertrations during Ery 2 Thropoietin Therapy in Patients with Uremia显示文摘Sergio D Emanuela C Danilo V 1992N Engl J Med1992,326,15:1
13显示文摘Licciardi M Emanuela F C Giammona G 2008Macromol Biosci2008,8,10:1
14Relief of pruritus and decrease in plasma histamine concentrations during erythropoietin therapy in patients with uremia显示文摘Sergio D Emanuela C Danilo V et la 1992N Eng J Med1992,326,1:1
15Relief of pruritus and decrease inplasma histamine concentrations during erythropoietin therapy in patientswith uremia 显示文摘Sergio D Emanuela C Danilo V 1992J Med1992,326,:1
16Enhancement of natural killer activity and interferon induction by different acyclic nucleoside phosphonates显示文摘Raffaele C Nicoletta V Emanuela B 1994Antivir ResVolume Issue1994,23,1:1
17Recruitment of circulating allergen-specific T lymphocytes to the lung on allergen challenge in asthma显示文摘Barbara B Giulia C Emanuela 1997J Allergy Clin Immun1997,100,:1
18Protective effects of n-acetylcysteine on lung injury and red blood cell modification induced by carrageenan in the rat 显示文摘Salvatore C Emanuela M Laura D 2001The FASEB Journal2001,15,:1
19Influence of severe plastic deformation on aging of AI-Mg-Si alloys显示文摘Emanuela C Paola L 2005Materials Science and Engineering A2005,,:1
20Relief of pruritus and decrease in plasma histamine concentrations during erythropoietin therapy in patients with uremia显示文摘Sergio D Emanuela C Danilo V 1992N Engl J Med1992,326,15:1
返回顶部 每页显示:
共4页 首页 上一页 第1页 下一页 末页 /4 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费